These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 12075401)

  • 21. The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571).
    DeMatteo RP
    Ann Surg Oncol; 2002 Nov; 9(9):831-9. PubMed ID: 12417503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review.
    Sawaki A; Yamao K
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S44-9. PubMed ID: 15309514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The diagnostic and predictive role of kit (CD117)].
    Dirnhofer S; Zimpfer A; Went P
    Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal stromal tumor: advances in diagnosis and management.
    Patil DT; Rubin BP
    Arch Pathol Lab Med; 2011 Oct; 135(10):1298-310. PubMed ID: 21970485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced or metastatic gastrointestinal stromal tumors: systemic treatment options.
    Caram MV; Schuetze SM
    J Surg Oncol; 2011 Dec; 104(8):888-95. PubMed ID: 22069173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)].
    Buleje S J; Yábar B A; Guevara-Fujita M; Fujita R
    Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes.
    Marano L; Boccardi V; Marrelli D; Roviello F
    Eur J Surg Oncol; 2015 Jul; 41(7):814-22. PubMed ID: 25956211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastrointestinal stromal tumor].
    Nishida T; Ohmori T; Matsuda H
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):331-6. PubMed ID: 15045935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Gastrointestinal Stromal Tumour: Current Practices and Visions for the Future.
    Blay JY; Casali PG; Dei Tos AP; Le Cesne A; Reichardt P
    Oncology; 2015; 89(1):1-13. PubMed ID: 25720422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal stromal tumor workshop.
    Berman J; O'Leary TJ
    Hum Pathol; 2001 Jun; 32(6):578-82. PubMed ID: 11431711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal stromal tumors (GIST)].
    Reichardt P; Pink D; Mrozek A; Lindner T; Hohenberger P
    Z Gastroenterol; 2004 Apr; 42(4):327-31. PubMed ID: 15095124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of gastrointestinal stromal tumors: from diagnosis to treatment.
    Bucher P; Villiger P; Egger JF; Buhler LH; Morel P
    Swiss Med Wkly; 2004 Mar; 134(11-12):145-53. PubMed ID: 15106018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Dagher R; Cohen M; Williams G; Rothmann M; Gobburu J; Robbie G; Rahman A; Chen G; Staten A; Griebel D; Pazdur R
    Clin Cancer Res; 2002 Oct; 8(10):3034-8. PubMed ID: 12374669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST).
    Logroño R; Jones DV; Faruqi S; Bhutani MS
    Cancer Biol Ther; 2004 Mar; 3(3):251-8. PubMed ID: 14726714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of malignant gastrointestinal stromal tumours.
    Joensuu H; Fletcher C; Dimitrijevic S; Silberman S; Roberts P; Demetri G
    Lancet Oncol; 2002 Nov; 3(11):655-64. PubMed ID: 12424067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor].
    Gelderblom H; Hogendoorn PC; van der Graaf WT; Verweij J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2051-5. PubMed ID: 14606351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High CD133 expression levels in gastrointestinal stromal tumors.
    Bozzi F; Conca E; Manenti G; Negri T; Brich S; Gronchi A; Pierotti MA; Tamborini E; Pilotti S
    Cytometry B Clin Cytom; 2011; 80(4):238-47. PubMed ID: 21462307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Novel HSP90 inhibitor, IPI-493, is highly effective in human gastrostrointestinal stromal tumor xenografts carrying heterogeneous KIT mutations.
    Floris G; Sciot R; Wozniak A; Van Looy T; Wellens J; Faa G; Normant E; Debiec-Rychter M; Schöffski P
    Clin Cancer Res; 2011 Sep; 17(17):5604-14. PubMed ID: 21737509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.